logo







Home>Companies>Tyra-biosciences-nas-tyra


Tyra biosciences (nas: tyra)

Tyra biosciences (nas: tyra)



Tyra Biosciences (NAS: TYRA) is a biotechnology company specializing in the development of advanced precision medicines targeting Fibroblast Growth Factor Receptor (FGFR) biology, with its lead candidate, TYRA-300, aimed at treating metastatic urothelial carcinoma of the bladder and urinary tract.
Sign up today to get real-time market insights on Tyra biosciences (nas: tyra) and hundreds of other pre-IPO companies



Tyra biosciences (nas: tyra) Overview

Carlsbad, CA, United States
2018
Biotech
https://www.tyra.bio



Tyra biosciences (nas: tyra) Live Market Data

$00000000
$00000000




Tyra biosciences (nas: tyra) Funding Rounds



RoundDateAmount RaisedValuationInvestorsSources
IPO9/15/2021
Series B3/31/2021
Series A1/6/2020




Tyra biosciences (nas: tyra) Investors



InvestorInvestment RoundsLead PartnerInitial InvestmentOther Notable Investments
Canaan PartnersSeries A, Series BSeries A (2020-01-06)
Janus Henderson Investors (NYS: JHG)Series BSeries B (2021-03-31)




Tyra biosciences (nas: tyra) 409a Valuations



DatePrice per shareEst. ValuationFilling
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Sign up to access Tyra biosciences (nas: tyra) data




Tyra biosciences (nas: tyra) Filings



TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign up to access Tyra biosciences (nas: tyra) data




Latest Tyra biosciences (nas: tyra) News







Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


DisclaimerAll investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.